Follicular thyroid neoplasm: Clinicopathologic features suggesting malignancy

APMIS

Volumn 118, Issue 11, 2010, Pages 846-854

  Heikkilä, Annukka ^a   Siironen, Päivi ^b   Hagström, Jaana ^a   Heiskanen, Ilkka ^b   Sankila, Risto ^c   Louhimo, Johanna ^b   Haglund, Caj ^a,b   Arola, Johanna ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c FINNISH CANCER REGISTRY   (Finland)

Author keywords

Cancer; Follicular tumors; Immunohistochemistry; Thyroid

Indexed keywords

ADULT; AGE; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER SIZE; CANCER SURGERY; CARCINOMA CELL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; THYROID ADENOMA; THYROID FOLLICULAR ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROIDECTOMY; TUMOR CELL; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR NECROSIS; TUMOR VOLUME; ADENOCARCINOMA; AGED; BIOSYNTHESIS; CLASSIFICATION; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; ONCOCYTOMA; PATHOLOGY; RETROSPECTIVE STUDY; THYROID TUMOR;

CCND1 PROTEIN, HUMAN; CYCLIN D1; MIB1 PROTEIN, HUMAN; PROTEIN P53; TP53 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

ADENOCARCINOMA, FOLLICULAR; ADENOMA, OXYPHILIC; ADULT; AGED; AGED, 80 AND OVER; CYCLIN D1; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES;

EID: 78149267661     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2010.02668.x     Document Type: Article

References (28)

1. Delbridge L. Solitary thyroid nodule: current management. ANZ J Surg 2006;76:381-6.
2. Sobrino Simoes M, Asa SL, Kroll TG, Nikiforov Y, DeLellis R, Farid P, Kitamura Y, et al. Follicular carcinoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. WHO Pathology & Genetics, Tumours of Endocrine Organs. Lyon: IARC Press, 2004: 67-72.
3. LiVolsi VA, Baloch ZW. Follicular neoplasms of the thyroid: view, biases, and experiences. Adv Anat Pathol 2004;11:279-87.
4. Liu S, Semenciw R, Ugnat A, Mao Y. Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects. Br J Cancer 2001;85:1335-9.
5. Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, et al. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 2008;20:525-31.
6. Reynolds RM, Weir J, Stockton DL, Brewster DH, Sandeep TC, Strachan MW. Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol(Oxf) 2005;62:156-62.
7. Netea-Maier R, Aben KK, Casparie MK, Den Heijer M, Grefte JM, Slootweg P, et al. Trends in incidence and mortality of thyroid carcinoma in the Netherlands between 1989 and 2003: correlation with thyroid fine-needle aspiration cytology and thyroid surgery. Int J Cancer 2008;123: 1681-4.
8. Lundgren CI, Hall P, Ekbom A, Frisell J, Zedenius J, Dickman PW. Incidence and survival of Swedish patients with differentiated thyroid cancer. Int J Cancer 2003;106:569-73.
9. DeLellis RA, Lloyd RV, Heitz PU, Eng C. WHO Pathology & Genetics Tumours of Endocrine Organs, 8th edn. Lyon: IARC Press, 2004.
10. Sobrino Simoes M, Albores-Saavedra J, Tallin G, Santero M, Volante M, Pilotti S, et al. Poorly differentiated carcinoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. WHO Pathology & Genetics, Tumours of Endocrine Organs. Lyon: IARC Press, 2004: 73-76.
11. Pulcrano M, Boukheris H, Talbot M, Caillou B, Dupuy C, Virion A, et al. Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification. Thyroid 2007;17:639-46.
12. Dobashi Y, Sakamoto A, Sugimura H, Mernyei M, Mori M, Oyama T, et al. Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma. Am J Surg Pathol 1993;17:375-81.
13. Rezk S, Khan A. Role of immunohistochemistry in the diagnosis and progression of follicular epithelium-derived thyroid carcinoma. Appl Immunohistochem Mol Morphol 2005;13:256-64.
14. Rickert D, Mittermayer C, Lindenfelser R, Biesterfeld S. MIB-1 immunohistometry of follicular adenoma and follicular carcinoma of the thyroid gland. Anal Quant Cytol Histol 2000;22:229-34.
15. Tallini G, Garcia-Rostan G, Herrero A, Zelterman D, Viale G, Bosari S, et al. Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. Am J Surg Pathol 1999;23:678-85.
16. Saiz AD, Olvera M, Rezk S, Florentine BA, McCourty A, Brynes RK. Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions. J Pathol 2002;198:157-62.
17. Pukkala E. Finnish Cancer Registry Institute for Statistical and Epidemiological Cancer Research, 2006. Available at: .
18. Tzen C, Huang Y, Fu Y. Is atypical follicular adenoma of the thyroid a preinvasive malignancy? Hum Pathol 2003;34:666-9.
19. Zdon MJ, Fredland AJ, Zaret PH. Follicular neoplasms of the thyroid: predictors of malignancy? Am Surg 2001;67:880-4.
20. Kushchayeva Y, Duh QY, Kebebew E, D'Avanzo A, Clark OH. Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hurthle cell or follicular thyroid cancer. Am J Surg 2008;195:457-62.
21. Cho Mar K, Eimoto T, Nagaya S, Tateyama H. Cell proliferation marker MCM2, but not Ki67, is helpful for distinguishing between minimally invasive follicular carcinoma and follicular adenoma of the thyroid. Histopathology 2006;48:801-7.
22. Thomas CG, Buckwalter JA. Poorly differentiated neoplasms of the thyroid. Ann Surg 1973;177:632-42.
23. Sakamoto A, Kasai N, Sugano H. Poorly differentiated carcinoma of the thyroid: a clinicopathological entity for a high-risk group of papillary and follicular carcinomas. Cancer 1983;52:1849-55.
24. Carcangiu ML, Zampi G, Rosai J. Poorly differentiated ("insular") thyroid carcinoma. A reinterpretation of Langhans'"wuchernde Struma". Am J Surg Pathol 1984;8:655-68.
25. Sobrinho-Simões M. Tumours of the thyroid: a brief overview with emphasis on the most controversial issues. Curr Diagn Pathol 1995;2: 15-22.
26. Sobrinho-Simões M, Sambade C, Fonseca E, Soares P. Poorly differentiated carcinomas of the thyroid gland: a review of the clinicopathologic features of a series of 28 cases of a heterogeneous, clinically aggressive group of thyroid tumors. Int J Surg Pathol 2002;10:123-31.
27. Ito Y, Hirokawa M, Fukushima M, Inoue H, Yabuta T, Uruno T, et al. Prevalence and prognostic significance of poor differentiation and tall cell variant in papillary carcinoma in Japan. World J Surg 2008;32:1544-5.
28. Siironen P, Nordling S, Louhimo J, Haapiainen R, Haglund C. Immunohistochemical expression of Bcl-2, Ki-67, and p21 in patients with papillary thyroid carcinoma. Tumour Biol 2005;26:50-6.